Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amaya Viros

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|November 25, 2011
(V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermisJoel Rae, Amaya Viros, Robert Hayward, et al.
European Journal of Endocrinology|May 14, 2011
Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based populationMerina Ahmed, Yolanda Barbachano, Angela Riddell, et al.
Science Translational Medicine|June 12, 2010
Gatekeeper mutations mediate resistance to BRAF-targeted therapiesSteven Whittaker, Ruth Kirk, Robert Hayward, et al.
Nature|June 12, 2014
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53Amaya Viros, Berta Sanchez-Laorden, Malin Pedersen, et al.
The Journal of Investigative Dermatology|August 17, 2012
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaAmaya Viros, Robert Hayward, Matthew Martin, et al.
Nature Communications|July 20, 2019
Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surfaceHaoRan Tang, Leo Leung, Grazia Saturno, et al.
Nature Communications|April 19, 2017
Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surfaceHaoRan Tang, Leo Leung, Grazia Saturno, et al.
Molecular Oncology|September 15, 2015
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cellsFranziska Baenke, Barbara Chaneton, Matthew Smith, et al.
Journal for Immunotherapy of Cancer|November 1, 2025
Systemic immunosuppression from ultraviolet radiation exposure inhibits cancer immunotherapyPedro Durao, Timothy Budden, Karthik Mallela, et al.
Genes & Development|November 17, 2007
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma developmentVéronique Delmas, Friedrich Beermann, Silvia Martinozzi, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|November 25, 2011
(V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermisJoel Rae, Amaya Viros, Robert Hayward, et al.
European Journal of Endocrinology|May 14, 2011
Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based populationMerina Ahmed, Yolanda Barbachano, Angela Riddell, et al.
Science Translational Medicine|June 12, 2010
Gatekeeper mutations mediate resistance to BRAF-targeted therapiesSteven Whittaker, Ruth Kirk, Robert Hayward, et al.
Nature|June 12, 2014
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53Amaya Viros, Berta Sanchez-Laorden, Malin Pedersen, et al.
The Journal of Investigative Dermatology|August 17, 2012
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaAmaya Viros, Robert Hayward, Matthew Martin, et al.
Nature Communications|July 20, 2019
Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surfaceHaoRan Tang, Leo Leung, Grazia Saturno, et al.
Nature Communications|April 19, 2017
Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surfaceHaoRan Tang, Leo Leung, Grazia Saturno, et al.
Molecular Oncology|September 15, 2015
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cellsFranziska Baenke, Barbara Chaneton, Matthew Smith, et al.
Journal for Immunotherapy of Cancer|November 1, 2025
Systemic immunosuppression from ultraviolet radiation exposure inhibits cancer immunotherapyPedro Durao, Timothy Budden, Karthik Mallela, et al.
Genes & Development|November 17, 2007
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma developmentVéronique Delmas, Friedrich Beermann, Silvia Martinozzi, et al.
Pageof 4